3-benzyl-1-ethyl-6-(4-methoxybenzyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione

ID: ALA4558003

PubChem CID: 155554655

Max Phase: Preclinical

Molecular Formula: C24H27N3O3

Molecular Weight: 405.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCn1c2c(c(=O)n(Cc3ccccc3)c1=O)CN(Cc1ccc(OC)cc1)CC2

Standard InChI:  InChI=1S/C24H27N3O3/c1-3-26-22-13-14-25(15-19-9-11-20(30-2)12-10-19)17-21(22)23(28)27(24(26)29)16-18-7-5-4-6-8-18/h4-12H,3,13-17H2,1-2H3

Standard InChI Key:  MKKPNDONGHKUKW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    5.4521  -19.8809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4521  -20.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1573  -21.1025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1573  -19.4681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8626  -19.8809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8592  -20.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2747  -19.8869    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5682  -19.4730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2712  -20.7040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5617  -21.1079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5705  -18.6558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9846  -19.4820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7432  -19.4743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9768  -21.1163    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5574  -21.9251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8475  -22.3299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6901  -19.8943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6837  -20.7115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3884  -21.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0992  -20.7188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1009  -19.8974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3956  -19.4888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0367  -19.8850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3283  -19.4754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6223  -19.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6243  -20.7034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3381  -21.1098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0412  -20.6974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9183  -21.1150    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2089  -20.7095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  5  8  1  0
  6 10  1  0
  9  7  1  0
  7  8  1  0
  9 10  1  0
  8 11  2  0
  7 12  1  0
  1 13  1  0
  9 14  2  0
 10 15  1  0
 15 16  1  0
 12 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 13 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4558003

    ---

Associated Targets(Human)

NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.50Molecular Weight (Monoisotopic): 405.2052AlogP: 2.65#Rotatable Bonds: 6
Polar Surface Area: 56.47Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.73CX LogP: 2.80CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.63Np Likeness Score: -1.06

References

1. Ma Z, Gao G, Fang K, Sun H..  (2019)  Development of Novel Anticancer Agents with a Scaffold of Tetrahydropyrido[4,3-d]pyrimidine-2,4-dione.,  10  (2): [PMID:30783502] [10.1021/acsmedchemlett.8b00531]

Source